Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04941807Phase 4Completed

Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome

Role: collaborator

NCT03689452Not ApplicableCompleted

The Effect of Platelet Rich Plasma on Non-scarring Alopecia

Role: collaborator

NCT02999737Phase 4Unknown

Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia

Role: collaborator

All 3 trials loaded